Millennium Cell Inc

Search in Documents
Key Exhibits
External Links

Material Contracts Filter

EX-10.1
from 8-K 5 pages January 31, 2008 by Facsimile [Holder] [Address] Reference Is Made to the Convertible Debentures of Millennium Cell Inc. (The “Company”), as Amended, With an Original Issue Date of February 16, 2007 in the Aggregate Outstanding Principal Amount, as of the Date Hereof, of $5,283,789 (The “Convertible Debentures”). in Consideration of the Mutual Covenants Contained Herein and Other Good and Valuable Consideration, the Receipt and Sufficiency of Which Are Hereby Acknowledged, the Undersigned and the Company Hereby Agree as Follows
12/34/56
EX-10.1
from 8-K 3 pages December 14, 2007 by Facsimile Portside Growth & Opportunity Fund C/O Ramius Capital Group, LLC 666 Third Avenue, 26th Floor New York, New York 10017 Attention: Jeffrey Smith Owen Littman Re: Series C2 Convertible Preferred Stock of Millennium Cell Inc
12/34/56
EX-10.2
from 8-K 7 pages Convertible Promissory Note Horizon Fuel Cell Technologies Pte Ltd. Due November 18, 2007 Preamble
12/34/56
EX-10.1
from 8-K 29 pages Securities Purchase and Sale Agreement by and Between Millennium Cell Inc. and Horizon Fuel Cell Technologies Pte. Ltd. October 19, 2007
12/34/56
EX-10.3
from 8-K 5 pages Retention Agreement
12/34/56
EX-10.2
from 8-K 10 pages Advisory Board Member Consulting Agreement
12/34/56
EX-10.1
from 8-K 11 pages Advisory Board Chairman Consulting Agreement
12/34/56
EX-10.1
from 10-Q 7 pages Millennium Cell Inc. Change-In-Control Agreement
12/34/56
EX-10.2
from 8-K 6 pages By Facsimile [Holder] [Address] Attention: Re: Amendment to Series C Warrants and Convertible Debentures and Termination of Registration Rights Agreement Ladies and Gentlemen
12/34/56
EX-10.1
from 8-K 13 pages July 25, 2007 the Dow Chemical Company 2030 Dow Center Midland, MI 48674 Attention: James H. Plonka Re: Amendment of Certain Terms of the Joint Development Arrangement Between Millennium Cell Inc. and the Dow Chemical Company. Ladies and Gentlemen
12/34/56
EX-10.1
from 8-K 3 pages [ May [__], 2007 by Facsimile [Name of Series C2 Holder] [Address of Series C2 Holder] Re: Amendment to the Letter Agreement, Dated February 15, 2007, Between Millennium Cell Inc. (The “Company”) and Certain Holders of the Company’s Series C2 Convertible Preferred Stock. Ladies and Gentlemen
12/34/56
EX-10.2
from 8-K/A 3 pages Confidential Mr. Adam Briggs 127 Lewis Lane Fair Haven, Nj 07724 Re: Certain Rights and Obligations Upon Termination of Employment Dear Adam
12/34/56
EX-10.1
from 8-K/A 8 pages By Facsimile [Name of Holder] [Address of Holder] Attention: Re: Amendment to Unsecured Convertible Debentures of Millennium Cell Inc. Ladies and Gentlemen
12/34/56
EX-10.1
from 8-K 2 pages February 15, 2007 by Facsimile [Name of Series C2 Holder] [Address of Series C2 Holder] Attention: Re: Series C2 Convertible Preferred Stock of Millennium Cell Inc
12/34/56
EX-10.3
from 8-K 3 pages Voting Agreement
12/34/56
EX-10.2
from 8-K 10 pages Registration Rights Agreement
12/34/56
EX-10.1
from 8-K 10 pages Securities Purchase Agreement
12/34/56
EX-10.1
from 8-K ~5 pages January 26, 2007 via Facsimile & U.S. Mail the Dow Chemical Company 2030 Dow Center Midland, MI 48674 Attention: Jim Plonka Re: Waiver of Adjustments to the Series B Conversion Price and Reduction of Warrant Exercise Price Ladies and Gentlemen
12/34/56
EX-10.5
from 8-K 4 pages Consulting Termination Agreement
12/34/56
EX-10.4
from 8-K 3 pages Target Termination Agreement
12/34/56